Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Autor:	Parikh, Mamta, Pan, Chong-Xian, Beckett, Laurel A., Li, Yueju, Robles, Daniel A., Aujla, Pawandeep K., Lara, Primo N., Jr.
Zdroj:	In Clinical Genitourinary Cancer December 2018 16(6):421-428
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect